|
NIPA1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.753700E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.506800E-01 |
| Normal-vs-Stage2 |
9.201600E-01 |
| Normal-vs-Stage3 |
9.241000E-03 |
| Normal-vs-Stage4 |
2.807100E-04 |
| Stage1-vs-Stage2 |
4.614800E-01 |
| Stage1-vs-Stage3 |
1.258010E-01 |
| Stage1-vs-Stage4 |
1.306400E-02 |
| Stage2-vs-Stage3 |
5.267900E-02 |
| Stage2-vs-Stage4 |
9.584200E-03 |
| Stage3-vs-Stage4 |
3.440800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.844300E-02 |
| Normal-vs-AfricanAmerican |
3.788200E-01 |
| Normal-vs-Asian |
1.139920E-02 |
| Caucasian-vs-AfricanAmerican |
8.363200E-01 |
| Caucasian-vs-Asian |
3.223400E-01 |
| AfricanAmerican-vs-Asian |
3.839000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.557400E-01 |
| Normal-vs-Female |
1.166410E-02 |
| Male-vs-Female |
3.025800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.818200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.064600E-03 |
| Normal-vs-Age(61-80Yrs) |
1.449350E-01 |
| Normal-vs-Age(81-100Yrs) |
2.194600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.285580E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.757200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.495800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.483400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.051600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.487800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.957900E-03 |
| Classical-VS-Follicular |
3.170100E-02 |
| Classical-VS-Other |
5.782400E-01 |
| Classical-VS-Normal |
5.458100E-02 |
| Tall-VS-Follicular |
4.42070000000738E-05 |
| Tall-VS-Other |
2.938800E-01 |
| Tall-VS-Normal |
2.146599999997E-05 |
| Follicular-VS-Other |
8.799000E-01 |
| Follicular-VS-Normal |
3.899200E-01 |
| Other-VS-Normal |
9.145000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.843800E-01 |
| Normal-vs-N1 |
1.213100E-04 |
| N0-vs-N1 |
2.835200E-03 |
|
|
